Thomas R. Fuerst - Concepedia

Author

Thomas R. Fuerst

Institute for Bioscience and Biotechnology Research ORCID

Also Known As

T Fuerst, T R Fuerst, T. FUERST, T. Fuerst, T. R. Fuerst, T.R. Fuerst, THOMAS R. FUERST, Thomas R. Fuerst, Thomas Fuerst, Thomas R Fuerst

101

Publications

9.2K

Citations

H-Index

Concepts

All Affiliations

Institute for Bioscience and Biotechnology Research University of Maryland, College Park National Institute of Allergy and Infectious Diseases Advanced Bioscience Laboratories (United States)National Institutes of Health

About

Thomas R. Fuerst is an author at Institute for Bioscience and Biotechnology Research specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	32	7.3K
2	Engineering	7	7	196
3	Natural Sciences	5	5	613
4	Biochemistry	2	2	282
5	Allergy	1	1	32

Thomas R. Fuerst

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Thomas R. Fuerst, Edward G. Niles, F. William Studier, Proceedings of the National Academy of Sciences VaccinationViral ReplicationMolecular VirologySynthetic VirologyMedicine	1986	2.1K
New use of BCG for recombinant vaccines C. Kendall Stover, Vidal F. de la Cruz, Thomas R. Fuerst, Nature VaccinationVaccinologyVaccine DevelopmentImmunologyNew Use	1991	1.5K
New mammalian expression vectors Bernard Moss, Orna Elroy‐Stein, Takuo Mizukami, Nature Protein ExpressionStem Cell ResearchGene Expression ProfilingGene ExpressionMedicine	1990	524
Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Thomas R. Fuerst, Patricia L. Earl, Bernard Moss Molecular and Cellular Biology VaccinationViral ReplicationMolecular VirologySynthetic VirologyViral Polymerase Mechanism	1987	411
Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Orna Elroy‐Stein, Thomas R. Fuerst, Bernard Moss Proceedings of the National Academy of Sciences Virus StructureViral ReplicationMolecular VirologyCap-independent TranslationEmcv Utr	1989	404
Demonstration of in Vitro Infection of Chimpanzee Hepatocytes with Hepatitis C Virus Using Strand-Specific RT/PCR Robert E. Lanford, Camille Sureau, James R. Jacob, Virology	1994	311
Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara Vanessa M. Hirsch, Thomas R. Fuerst, Gerd Sutter, Journal of Virology VaccinationPlasma ViremiaViral PersistencePrimary Plasma ViremiaHuman Retrovirus	1996	304
Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro H. William Schnaper, Derrick S. Grant, William G. Stetler‐Stevenson, Journal of Cellular Physiology	1993	296
Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein Vijay K. Chaudhary, Tamio Mizukami, Thomas R. Fuerst, Nature Selective KillingHuman RetrovirusHiv-infected CellsImmunologyAntiviral Response	1988	254
Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. Rafael Fridman, Thomas R. Fuerst, Robert E. Bird, Journal of Biological Chemistry ImmunologyViral Structural ProteinProtein ExpressionTissue InhibitorMatrix Biology	1992	202

Page 1